T-Cell Malignancies

Aug 28, 2026

Summary Peripheral T-cell lymphoma (PTCL) is a rare and aggressive group of mature T-cell malignancies, representing approximately 10–15% of non-Hodgkin lymphomas in the US. CHOP remains the standard first-line treatment, but its intensive cytotoxic profile limits use in some patients.  ADCETRIS (brentuxi...

Aug 21, 2026

Summary T-cell malignancies, including Peripheral T-cell Lymphomas (PTCL) and cutaneous entities such as Cutaneous T-cell Lymphoma (CTCL), comprise a diverse and often aggressive group of cancers that are generally associated with poorer clinical outcomes compared with B-cell malignancies. The current CTCL t...